CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions

• Conditions: Habitual Abortion

• Registration Number: NCT01644318
• Lead Sponsor: Ankara Education and Research Hospital

Brief Summary

The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

Detailed Description

Not available

Study Timeline

• Status Verified: 2012-07
• Study First Submitted: 2012-07-17
• Study First Submitted QC: 2012-07-18
• Last Update Submitted: 2012-07-18
• Study First Posted: 2012-07-19
• Last Update Posted: 2012-07-19

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• non-pregnant women with euthyroid autoimmune thyroiditis and a history of first trimester recurrent spontaneous abortions

Exclusion Criteria

• 1. presence of acute or chronic systemic diseases; 2) other autoimmune diseases; 3) pregnancy and lactation over the previous 6 months; 4) evidence of infectious diseases in the last 3 months; 5) treatment with drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs, amiodarone, and lithium; 6) clinical history of hyperthyroidism and/or the presence of anti-TSH receptor antibodies.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

Trial Locations

Locations (1)

Ankara Education and Research Hospital; 🇹🇷 Ankara, Turkey